Nucleic acid-triggered tumoral immunity propagates pH-selective therapeutic antibodies through tumor-driven epitope spreading.
Furuya G, Katoh H, Atsumi S, Hashimoto I, Komura D, Hatanaka R, Senga S, Hayashi S, Akita S, Matsumura H, Miura A, Mita H, Nakakido M, Nagatoishi S, Sugiyama A, Suzuki R, Konishi H, Yamamoto A, Abe H, Hiraoka N, Aoki K, Kato Y, Seto Y, Yoshimura C, Miyadera K, Tsumoto K, Ushiku T, Ishikawa S.
Furuya G, et al. Among authors: suzuki r.
Cancer Sci. 2023 Jan;114(1):321-338. doi: 10.1111/cas.15596. Epub 2022 Oct 17.
Cancer Sci. 2023.
PMID: 36136061
Free PMC article.